Navigation Links
Rentschler Biotechnologie erweitert Kapazitten fr Produktion in Sugetierzellen
Date:6/20/2008

Laupheim, 20. Juni 2008 / b3c newswire / - Rentschler Biotechnologie, ein führendes Auftragsunternehmen zur Herstellung moderner biopharmazeutischer Arzneimittel gibt die Inbetriebnahme einer 2.500 Liter Produktionsanlage bekannt. Damit verfügt das Unternehmen nun über neun unabhängige GMP-Produktionslinien mit Arbeitsvolumen von 30, 250, 500 und 2.500 Litern für die Herstellung von klinischen Prüfmustern und für die Marktproduktion.

Der moderne 2.500 L-Bioreaktor ist auf dem neuesten Stand der Technik und so ausgelegt, dass je nach Anforderung unterschiedliche Zellkulturprozesse, wie Batch, Fed-Batch oder Perfusion, eingesetzt werden können. Die Proteinreinigung erfolgt dann in zwei Suiten für Prä- und Post-Virusinaktivierung.

Mit seinen modernen GMP-Produktionsanlagen bietet Rentschler Biotechnologie seinen Kunden ein umfassendes Leistungsangebot „vom Gen bis zum Arzneimittel“. Das Unternehmen kann für seine Kunden maßgeschneiderte Herstellprozesse entwickeln und eine langfristige Partnerschaft über die Entwicklungs- und Vermarktungsphasen hinweg anbieten. Aufgrund einer Kooperations-Vereinbarung mit Boehringer Ingelheim erhalten solche Kunden, deren  Produktionsbedarf die Kapazitäten von Rentschler übersteigt, Zugang zu Boehringer Ingelheims großtechnischen Anlagen mit Bioreaktor-Volumen bis zu 15.000 Litern.

Der weltweite Markt für biopharmazeutische Arzneimittel und damit auch der Bedarf an entsprechenden Produktionskapazitäten befinden sich in stetem Wachstum. Aus diesem Grund hat Rentschler Biotechnologie seit 2002 mehr als 70 Millionen Euro in die Erweiterung seiner Produktionskapazitäten investiert. Dadurch hat Rentschler seine Position als Auftragshersteller für Biopharmazeutika gefestigt und zählt heute zu den drei führenden europäischen Dienstleistungsunternehmen in diesem M
'/>"/>

www.b3c.de

1

GOOD

Page: 1 2

Related biology technology :

1. Rentschler Biotechnologie Announces Cooperation with Boehringer Ingelheim
2. Rentschler Biotechnologie Extends Capacities for Mammalian Cell Culture Manufacturing
3. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
4. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
5. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
6. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
7. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
8. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
9. Amyris Biotechnologies Announces $70 Million Series B Round
10. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
11. Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013 Nasseo, Inc. today ... Challenge Winner out of hundreds of applicants by the ... Arizona Innovation Challenge . The Arizona Innovation Challenge ... a technology commercialization challenge, granting a financial award to ... technology ventures. Nasseo’s state of the art dental and ...
(Date:6/18/2013)... Delaware , June 18, 2013 ... announce the release of the HELM biomolecular representation ... open source MIT licence. HELM (Hierarchical ... a wide range of biomolecules (e.g. proteins, nucleotides, ... existing small-molecule and sequence-based informatics methodologies impractical or ...
(Date:6/18/2013)... , June 18, 2013 ... investment research firm, announces the initiation of ... French biopharmaceutical company developing and marketing products ... indications.      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... report examining the investment merits of BioAlliance ...
(Date:6/18/2013)... The "Bioinformatics Market By Sector (Molecular Medicine, Agriculture, Research & ... Services) & Application (Genomics, Proteomics & Drug Design) - Global Forecasts to ... Opportunities in North America , ... of World. Browse , 120 ... 364 Pages and an in-depth Table of ...
Breaking Biology Technology:Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Bioinformatics Market Worth $7.5 Billion by 2017 2Bioinformatics Market Worth $7.5 Billion by 2017 3
... are stunning. Others are not mismatched fonts, poorly aligned ... deluge of data presents a challenge to amateur designers, often ... figure,s main message. A group of University of Washington researchers ... those in design. The new Design Help Desk, similar to ...
... University have discovered a way to make a low-cost material ... a goal first theorized in 1861 by a giant ... wide practical use. Other materials can do this but ... way that yields the same result will have extraordinary possibilities, ...
... - February 23, 2012 Engineers at Harvard have demonstrated ... nanoantennas to obtain precise control of color output. Whereas ... a single active filter under exposure to different types of ... has the potential for application in televisions and biological imaging, ...
Cached Biology Technology:Design eye for the science guy: Drop-in clinic helps scientists communicate data 2Design eye for the science guy: Drop-in clinic helps scientists communicate data 3Discovery opens door to low-cost 'negative refraction,' new products and industries 2Metal nanoparticles shine with customizable color 2
(Date:6/18/2013)... At Brandeis University, sophisticated computational models and advances ... the complex interplay between genomic data, virus structure ... critical for replication. , "We ... will help researchers alter virus assembly, leaving viruses ... first author of the scientific paper describing the ...
(Date:6/18/2013)... Washington, D.C. June 18, 2013 Joshua Obar, ... UniversityBozeman, has been honored with a 2013 ICAAC Young ... the regulation of immunological memory responses to infection. ... Wesleyan University in 2001 and went on to complete ... in 2006. He performed his Ph.D. thesis research ...
(Date:6/18/2013)... to a chemical modification of DNA and this ... the DNA sequence. Until now, scientists believed that ... certain genes. Today, a team of researchers from ... Emmanouil Dermitzakis, Louis-Jeantet Professor at the Faculty of ... case and that DNA methylation may play both ...
Breaking Biology News(10 mins):Computer modeling technique goes viral at Brandeis 2The American Society for Microbiology honors Joshua Obar 2The secret of DNA methylation 2
... of Alberta researchers has created technology to regrow teeth--the ... dental tissue. , Using low-intensity pulsed ultrasound (LIPUS), Dr. ... and Dr. Jie Chen and Dr. Ying Tsui from ... that offers a non-invasive and novel way to stimulate ...
... COX-2 enzymes may be blocked by pain medications such ... than was previously understood, a Queen's University study has ... implications for how we classify the commonly used anti-inflammatory ... Colin Funk, a professor of Biochemistry and Physiology at ...
... Noel Dahl and Mohammad F. Islam have made a ... disease that accelerates the aging process by about seven ... of chemical and biomedical engineering at Carnegie Mellon, said ... of the National Institutes of Health (NIH), the John ...
Cached Biology News:Ultrasound may help regrow teeth 2New understanding of COX-1 and COX-2 enzymes could revise classification of pain meds 2Carnegie Mellon researchers discover new cell properties 2
Cytofix/Cytoperm Plus Kit with GolgiPlug 250 Tests...
Rabbit polyclonal to 3-Ethynylestradiol ( Abpromise for all tested applications). Antigen: Ethynylestradiol conjugated to BSA....
Antibody specific for histone H3 acetylated at any of the five N-terminal lysine residues. Rabbit polyclonal serum. Antigen: Synthetic peptide derived from histone H3 N-terminal region, mulitpliy...
NuCycl DAPI Kit Application: Flow Cytometry Reactivity: Human...
Biology Products: